Monte Rosa Therapeutics Inc (GLUE)

Net Income Growth

-766.65%

TTM · Period ending:

GLUE logo

GLUE Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-766.65%
GLUE TTM Net Income YoY % (-106.13% → -766.65%)
High-resolution chart · PNG

GLUE net income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Monte Rosa Therapeutics Inc Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income Growth
-766.6501%
-2,213.018%
46.8693%
117.5443%
118.5318%
104.5483%
46.2882%
10.1541%
-4.0681%
-16.0153%
-24.7472%
-31.3595%
-33.7731%
-36.2009%
-46.7062%
-44.1545%
-64.6507%
-95.2251%
-106.126%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.